Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and tolerability of AWT020 in patients with advanced malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Other Solid Tumor
• Renal Cell Carcinoma

Drugs mentioned

• AWT020

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor | Phase 1 | Status: RECRUITING